- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 16.1M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 17.73M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 18.84M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $679K |
| Capex | Q1 2026 · Mar 31, 2025 | $647K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$231K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$955K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $66.99M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $58.04M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $18.11M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $95.73M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $129.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $146.7M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $133.65M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $357.12M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $317.61M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $452.85M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $447.01M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.15 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.80 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.15 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.80 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.01M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.98M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.58M |
| Net Income | Q1 2026 · Mar 31, 2025 | $15M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $966K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $998K |
| Revenue | Q1 2026 · Mar 31, 2026 | $12.56M |
| Revenue | Q1 2026 · Mar 31, 2025 | $13.61M |